ArticlePharmaceuticals (Basel, Switzerland)2023

Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.

Irma Convertino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.